Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Bicycle Therapeutics plc BCYC

Set alert

Price alert · BCYC

All alert types
3.62 USD -0.04 -1.09%

At close · Nov 2

3.62 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
3.60 × 4
Ask
3.62 × 2
3.58 Day range 3.76
3.33 52-week range 7.83
YTD
-48.87%
1 year
-55.14%
Open
3.69
Prev close
3.66
Mkt cap
253.74M
Vol
348.24K
Avg vol
414.49K
EPS
-2.03
P/E
0.00
Div yield
0.00%
More statistics
Low
3.58
High
3.76
Forward P/E
-3.09
Beta
0.93
Short ratio
14.44
Inst. own
92.44%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
13.38
200-d avg
20.47
1y target
29.55

3M chart

Chart tools
Interval
1m5m15m30m

Signals (24)
NameDateAgo
SMA: BearishOct 30, 20263 days ago
SMA: BearishOct 29, 20264 days ago
SMA: BullishOct 28, 20265 days ago
SMA: BullishOct 27, 20266 days ago
MACD: Buy SignalOct 22, 20261 week ago
MACD: Sell SignalOct 16, 20262 weeks ago
SMA: BearishOct 12, 20263 weeks ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BearishOct 6, 20263 weeks ago
SMA: BearishOct 6, 20263 weeks ago
SMA: BullishOct 5, 20264 weeks ago
SMA: BullishOct 5, 20264 weeks ago
MACD: Buy SignalOct 5, 20264 weeks ago
SMA: BearishSep 9, 20261 month ago
SMA: BearishSep 9, 20261 month ago
MACD: Sell SignalSep 8, 20261 month ago
SMA: BullishSep 2, 20262 months ago
SMA: BullishAug 19, 20262 months ago
SMA: BullishAug 19, 20262 months ago
SMA: BearishAug 10, 20262 months ago

Newest 20 of 24.

Analyst view

Consensus: buy

Buy
Price target (mean) 29.55 +716.2% upside
Target (low)
13.00
Target (mean)
29.55
Target (high)
48.00
Ratings (0m) 13 10 buy · 3 hold · 0 sell
  • Strong buy5
  • Buy5
  • Hold3
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 13
  • 1 month ago 13
  • 2 months ago 13
  • 3 months ago 13

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BCYC analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.805-0.905 – -0.69-0.62-29.8%8.67M-55.6%5
Next quarter-0.8206-0.943 – -0.69-0.77-6.6%7.86M-16.0%5
Current year-3.32-3.84 – -2.880.000.0%34.56M-2.0%8
Next year-3.88-4.39 – -3.31-3.32-17.0%33.44M-3.3%7

Upgrades and downgrades

The latest rating changes

BCYC analyst upgrades and downgrades
DateFirmActionFromTo
Feb 26, 2025Citizens Capital MarketsReiteratedMarket OutperformMarket Outperform
Feb 26, 2025HC Wainwright & Co.ReiteratedBuyBuy
Feb 26, 2025NeedhamReiteratedBuyBuy
Jan 22, 2025Stephens & Co.ReiteratedEqual-WeightEqual-Weight
Jan 13, 2025HC Wainwright & Co.ReiteratedBuyBuy
Jan 13, 2025NeedhamReiteratedBuyBuy
Dec 18, 2024JMP SecuritiesMaintainedMarket OutperformMarket Outperform
Dec 16, 2024HC Wainwright & Co.MaintainedBuyBuy
Dec 13, 2024B. Riley SecuritiesMaintainedNeutralNeutral
Nov 8, 2024Stephens & Co.Initiated—Equal-Weight
Nov 1, 2024RBC CapitalReiteratedOutperformOutperform
Nov 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 31, 2024NeedhamReiteratedBuyBuy
Oct 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 24, 2024NeedhamReiteratedBuyBuy
Sep 16, 2024JMP SecuritiesReiteratedMarket OutperformMarket Outperform
Sep 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 16, 2024NeedhamReiteratedBuyBuy
Sep 9, 2024NeedhamReiteratedBuyBuy
Sep 9, 2024Cantor FitzgeraldReiterated—Overweight
Sep 6, 2024RBC CapitalInitiated—Outperform
Aug 7, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 7, 2024OppenheimerMaintainedOutperformOutperform
Aug 7, 2024NeedhamReiteratedBuyBuy
Aug 7, 2024B. Riley SecuritiesDowngradeBuyNeutral
May 3, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 10, 2024NeedhamReiteratedBuyBuy
Feb 21, 2024Canaccord GenuityReiteratedBuyBuy
Feb 21, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 21, 2024NeedhamReiteratedBuyBuy